Kardia's single lead EKG is comparable to Lead 1 of standard EKG machines, and the most clinically validated mobile EKG solution available 1.
"From its early days, I've studied and published peer-reviewed research on the AliveCor device. I think it is one of the more important technologies in recent years that enables large scale healthcare awareness and literacy."
Looking for fast, accurate in-office EKG screening? Kardia captures rate-and-rhythm, and determines whether a confirmatory 12-lead EKG is necessary in just 30 seconds.
"One of my challenges as a cardiologist is to correlate heart rhythm with symptoms, and that can only happen when I'm able to look at what's going on with a patient at a time when they're symptomatic. Once you've done that it is then possible to modify these inciting factors to ensure that their impact is reduced."
Patients can self-administer an EKG whenever they feel symptoms or on a schedule you recommend - giving you a more complete picture of your patients' heart activity. EKG data can be stored for upcoming appointments, or shared with you instantly via email or the secure patient dashboard. And you decide how and when to review EKGs.
"I now have a more complete view of what's happening with my patients between three or six month appointments, specifically their AF episodes and medications. My patients can also send me this information quickly, even during an AF episode, helping me give them immediate advice about what to do next."
Kardia is rated 4.3 out of 5 stars on Amazon and has been shown by a Cleveland Clinic study 2 as a viable post-ablation monitoring alternative to a transtelephonic monitor (TTM), with 100% sensitivity, 97% specificity for detection of atrial fibrillation and atrial flutter combined, and 92% patient preference for AliveCor vs. the traditional TTM. Patients who self-test and detect normal sinus rhythm report increased peace of mind…which may reduce the need for ER visits.
"I probably had occasional attacks of paroxysmal atrial fibrillation for many years, but it was never diagnosed despite many studies. With AliveCor it was detected and documented within a few months."
I have been using the AliveCor Kardia for over a year. It is extremely comforting to get results instantly and for my cardiologist to be able to review them. It gives me peace of mind to go on with my life.
1 Based on the number of published clinical studies using Kardia Mobile compared to other smartphone-based EKG devices.
2 Khaldoun G. Tarakji et al. “Using a Novel Wireless System in Monitoring patients After Atrial Fibrillation Ablation Procedure. The iTransmit Study.” HeartRhythm. In Press. Published online: November 2014